MENU

NEWSROOM

Title

  1. 'China solution' targets high-risk breast cancer
  2. FUSCC’s TORCH‑E Study Published in Clinical Cancer Research: 72.7% Complete Response Rate in Early Low Rectal Cancer
  3. A “Mount Everest–Level” Surgical Demonstration at the 36th Italian Congress of Digestive Surgery
  4. A Multi-Cohort Analysis from "Fudan University Shanghai Cancer Center" Reveals Global Patterns in Genomic Mutations among Patients with Early-Onset Colorectal Cancer
  5. Fudan University Team Led by Sheng Weiqi and Xu Midie Reports CCT6A Modulates Tumor Microenvironment via Intercellular Shuttling, Establishing a Pro-Tumor "Metabolic Niche"
  6. Fudan University Shanghai Cancer Center Convenes Virtual Meeting with Centre Antoine Lacassagne to Forge Future Collaboration
  7. Fudan University Shanghai Cancer Center Breakthrough Discovery: “Metabolic Waste” Offers New Hope for Immunotherapy in "King of Cancers"
  8. Nature | Xu Yanhui team uncovers the dynamics of RNA polymerase III transcription initiation
  9. A new breakthrough of immunotherapy for luminal-type breast cancer
  10. Voice of China at ESSO | FUSCC was invited to the international stage, showcasing the wisdom and elegance of Chinese colorectal oncologists